Clinical Outcomes of Faricimab in Patients with Previously Treated Neovascular Age-Related Macular Degeneration-Reference-Cited by-同舟云学术

Clinical Outcomes of Faricimab in Patients with Previously Treated Neovascular Age-Related Macular Degeneration

Published:2023-10 Issue: Volume: Page:
ISSN:2468-6530
Container-title:Ophthalmology Retina
language:en
Short-container-title:Ophthalmology Retina

Author:

Pandit Saagar A.,Momenaei Bita^ORCID,Wakabayashi Taku^ORCID,Mansour Hana A.^ORCID,Vemula Sudheshna,Durrani Asad F.^ORCID,Pashaee Bahram,Kazan Adina S.,Ho Allen C.^ORCID,Klufas Michael^ORCID,Regillo Carl,Yonekawa Yoshihiro,Hsu Jason,Kuriyan Ajay^ORCID,Chiang Allen^ORCID

Publisher

Elsevier BV

Subject

Ophthalmology

Reference29 articles.

1. Ranibizumab for neovascular age-related macular degeneration;Rosenfeld;N Engl J Med,2006

2. Ranibizumab versus verteporfin for neovascular age-related macular degeneration;Brown;N Engl J Med,2006

3. Treat-and-extend versus monthly regimen in neovascular age-related macular degeneration: results with ranibizumab from the TREND study;Silva;Ophthalmology,2018

4. Prospective trial of treat-and-extend versus monthly dosing for neovascular age-related macular degeneration: TREX-AMD 1-year results;Wykoff;Ophthalmology,2015

5. Ranibizumab or bevacizumab for neovascular age-related macular degeneration according to the Lucentis Compared to Avastin Study treat-and-extend protocol: two-year results;Berg;Ophthalmology,2016

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dual pathway inhibition with faricimab for previously treated neovascular age-related macular degeneration and diabetic macular oedema: guidance from a UK panel of retina specialists;Eye;2024-08-30

2. Real-world efficacy of intravitreal faricimab for neovascular age-related macular degeneration: a systematic review;International Journal of Retina and Vitreous;2024-07-12

3. Real-World Outcomes of a Loading Phase with Intravitreal Faricimab in Neovascular Age-Related Macular Degeneration (n-AMD) and Diabetic Macular Edema (DME);Ophthalmology and Therapy;2024-06-04

4. Real-World Outcomes of Faricimab Treatment for Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema;Clinical Ophthalmology;2024-05

5. Retinal and choroidal efficacy of switching treatment to faricimab in recalcitrant neovascular age related macular degeneration;Scientific Reports;2024-04-26